Hims & Hers Health, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
It was overall a positive result, with revenues beating expectations by 4.9% to hit US$402m. Hims & Hers Health also reported a statutory profit of US$0.32, which was an impressive 534% above what the analysts had forecast. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Hims & Hers Health after the latest results. Check out our latest analysis for Hims & Hers Health Taking into account the latest results, the current consensus from Hims & Hers Health's twelve analysts is for revenues of US$2.04b in 2025. This would reflect a huge 64% increase on its revenue over the past 12 months. Statutory per-share earnings are expected to be US$0.46, roughly flat on the last 12 months. Before this ear
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Hims & Hers Expands Nutrition Support to Fuel Customers' Weight Loss Journeys [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss JourneysBusiness Wire
- Hims & Hers Health: Far From Dead, Even With Amazon's Threat Ahead [Seeking Alpha]Seeking Alpha
- Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at TD Cowen. They now have a $28.00 price target on the stock.MarketBeat
- Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 11/4/24 - Beat
HIMS
Sec Filings
- 11/21/24 - Form 8-K
- 11/19/24 - Form 4
- 11/19/24 - Form 4
- HIMS's page on the SEC website